Latest Low dose naltrexone Stories

2011-09-02 12:19:40

Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered the mechanism by which a low dose of the opioid antagonist naltrexone (LDN), an agent used clinically (off-label) to treat cancer and autoimmune diseases, exerts a profound inhibitory effect on cell proliferation. It has been postulated that opioid receptor blockade by LDN provokes a compensatory elevation in endogenous opioids and opioid receptors that can function after LDN is no...

2011-07-12 22:35:33

Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that a low dose of the opioid antagonist naltrexone (LDN) has an extraordinarily potent antitumor effect on human ovarian cancer in tissue culture and xenografts established in nude mice. When LDN is combined with chemotherapy, there is an additive inhibitory action on tumorigenesis. This discovery, reported in the July 2011 issue of Experimental Biology and Medicine, provides new...

2009-08-25 10:49:00

CAMBRIDGE, Mass., Aug. 25 /PRNewswire/ -- Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases. The Phase Ib multiple-ascending dose, double-blind, placebo-controlled, randomized...

2009-04-29 12:47:00

Aurora St. Luke's Team Sees Lives Changed for the Better with Plasma Exchange. MILWAUKEE, April 29 /PRNewswire/ -- Researchers at Aurora St. Luke's Medical Center in Milwaukee report that plasma exchange therapy or PLEX dramatically improves the health of multiple sclerosis patients who fail to respond to conventional therapies. (Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b) "There is no other treatment that brings about such a reversal in multiple sclerosis," says...

2009-04-23 13:45:47

An inexpensive drug that has been used for years to treat opioid addiction may be the key to relieving pain for millions of fibromyalgia sufferers. Fibromyalgia is a disorder that affects an estimated 4 percent of the population, yet there is no well-established and objective blood test to confirm its diagnosis. Sufferers report experiencing chronic widespread pain, debilitating fatigue, sleep disturbance and joint disorders. A small pilot study at Stanford University tested the effect of a...

Word of the Day
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.